Plasmodium falciparum encodes a conserved active inhibitor-2 for Protein Phosphatase type 1: perspectives for novel anti-plasmodial therapy
1 Center for Infection and Immunity of Lille, Inserm U1019-CNRS UMR 8204, University of Lille Nord de France, Institut Pasteur de Lille, 1 Rue du Professeur Calmette, 59019 Lille, Cedex, France
2 EA4479, IFR147, Laboratoire de Régulation des Signaux de Division, SN3, Université des Sciences et Technologies de Lille, 59655 Villeneuve d’Ascq, France
BMC Biology 2013, 11:80 doi:10.1186/1741-7007-11-80Published: 9 July 2013
Additional file 1: Table S1:
List of the primers used throughout this study.
Format: TIFF Size: 582KB Download file
Additional file 2: Figure S1:
Nucleotide sequence of P. falciparum inhibitor 2. Sequence of PfI2 obtained by RT-PCR using different sets of primers to confirm the start and the stop codons. The 5′ and 3′ non -coding sequences are presented in italic. The start and stop codons are bolded.
Format: TIFF Size: 1.1MB Download file
Additional file 3: Table S2:
list of the peptides used throughout this study.
Format: TIFF Size: 145KB Download file
Additional file 4: Table S3:
list of the proteins present in genomic database used in the phylogenetic analysis.
Format: TIFF Size: 3.4MB Download file
Additional file 5: Figure S2:
Optimized sequence of PfI2 used throughout this study for recombinant protein expression and interaction studies in yeast.
Format: TIFF Size: 819KB Download file